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Abstract
Objectives
To assess the diagnostic value of dual energy spectral CT imaging for colorectal cancer
grading using the quantitative iodine density measurements in both arterial phase (AP) and
venous phase (VP).
Methods
81 colorectal cancer patients were divided into two groups based on their pathological find-
ings: a low grade group including well (n = 13) and moderately differentiated cancer (n =
24), and a high grade group including poorly differentiated (n = 42) and signet ring cell can-
cer (n = 2). Iodine density (ID) in the lesions was derived from the iodine-based material
decomposition (MD) image and normalized to that in the psoas muscle to obtain normalized
iodine density (NID). The difference in ID and NID between AP and VP was calculated.
Results
The ID and NID values of the low grade cancer group were, 14.65±3.38mg/mL and 1.70
±0.33 in AP, and 21.90±3.11mg/mL and 2.05± 0.32 in VP, respectively. The ID and NID val-
ues for the high grade cancer group were 20.63±3.72mg/mL and 2.95±0.72 in AP, and
26.27±3.10mg/mL and 3.51±1.12 in VP, respectively. There was significant difference for
ID and NID between the low grade and high grade cancer groups in both AP and VP (all
p<0.001). ROC analysis indicated that NID of 1.92 in AP provided 70.3% sensitivity and
97.7% specificity in differentiating low grade cancer from high grade cancer.
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Conclusions
The quantitative measurement of iodine density in AP and VP can provide useful informa-
tion to differentiate low grade colorectal cancer from high grade colorectal cancer with NID
in AP providing the greatest diagnostic value.
Introduction
Colorectal cancer (CRC) has become a very common malignant tumor and one of the leading
causes of cancer-related death in western countries [1] and more so in China in recent years.
The 5-year survival rate following surgical intervention is approximately 50% [2]. Most studies
have focused on colorectal cancer staging [3–7]. However, few studies have evaluated tumor
grading. Tumor grade closely relates to degree of malignancy. A higher tumor grade suggests a
poorer prognosis and reduced tumor cell differentiation. This also implies an easier ability to
metastasize and higher rate of recurrence [8]. Adenocarcinoma is the most common type of
colorectal cancer. According to the fourth edition of WHO Classification of Tumors of the
Digestive System [9], adenocarcinoma is graded predominantly on the basis of the extent of
glandular appearance, and should be divided into well, moderately and poorly differentiated
types. Another method of classification is to divide the cancer into low-grade (encompassing
well and moderately differentiated adenocarcinomas) and high-grade (including poorly differ-
entiated adenocarcinomas and undifferentiated carcinomas). Poorly differentiated adenocarci-
nomas should show at least some gland formation or mucus production; tubules are typically
irregularly folded and distorted. For this study we employed the latter classification method.
Modern imaging technology allows for detection and noninvasive staging of disease. Large
tumors can be detected by conventional barium enema, while air-contrast radiography
improves the visualization of less advanced lesions. Examinations such as CT, MRI, and trans-
rectal ultrasonography, allow for the assessment of local tumor invasion and the presence of
locoregional and distant metastases [10]. But the tumor grading research through CT imaging
is seldom for lack of quantitative density measurement. Dual energy spectral CT (DEsCT) was
recently introduced as a method of furthering diagnostic capabilities. Different from previous
dual energy approaches, DEsCT employs a single x-ray tube producing dual energy spectra
through rapidly alternating high and low tube voltage [11, 12]. Spectral CT produces a material
decomposition (MD) image pair (e.g. water- and iodine-based material decomposition images)
for accurate material density quantification. The aim of this study is to assess the feasibility and
diagnostic value of dual energy spectral CT imaging for colorectal cancer grading using the




This retrospective study was approved by Renji hospital institutional review board, and written
informed consent was obtained. A total of 81 patients underwent CT with spectral imaging
between February 2010 and October 2013 (46 men, 35 women; mean age, 62.3 years). Follow-
ing CT imaging, all patients were treated surgically with standard pathologic grading. This
cohort included 13 cases of well differentiated adenocarcinoma, 24 cases of moderately differ-
entiated adenocarcinoma, 42 cases of poorly differentiated adenocarcinoma, and 2 cases of
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signet ring cell cancer. Undifferentiated colon adenocarcinoma patients were not included
because no such cases have been collected in our study. Patients were divided into low and
high grade groups based on the pathological findings. The low grade cancer group included
well differentiated colon adenocarcinoma and moderately differentiated colon adenocarci-
noma. The high grade cancer group included poorly differentiated colon adenocarcinoma and
signet ring cell cancer.
Patient preparation for spectral CT scan
All patients underwent standard cathartic preparation. Patients were asked to avoid products
containing fiber, and to restrict their diet to fish, eggs, meat, and milk three days prior to their
CT. Patients were administered polyethylene glycol oral laxatives twenty four hours before CT
examination. The CT was performed following administration of a 1–1.5L gravity fed water
enema (CT-WE), administered over the course of 3–4 minutes in the prone position, with dis-
tension dependent on patient comfort and tolerance.
CT examination protocol
CT scans were performed on a Discovery CT750HD (GE Healthcare, Wisconsin, USA) scan-
ner. The helical scan range was determined by a scout scan, and included the entire abdomen
from the diaphragms to the pubic symphysis. Following the scout scan, a conventional non-
enhanced helical scan was obtained at 120 kVp. Patients were then injected with a total dose of
100-140mL (1.8 mL per kilogram of body weight) of nonionic iodinated contrast material
(Iopamidol 370 mg/mL; Shanghai Bracco Sine Phamaceutical Co., Ltd., China) at a rate of 3.5
mL/s followed by 50 mL saline solution using a power injector. Contrast-enhanced CT scans
were performed in the arterial phase and venous phase with spectral CT imaging. Bolus track-
ing was utilized with the region of interest placed in the aorta, and image acquisition started 7 s
after the signal attenuation reached the predefined threshold of 100 Hounsfield units (HU) for
the arterial phase. A 45-second delay was utilized as the venous phase.
A pre-defined spectral CT scan protocol was used which included the following parameters:
tube current 600mA, gantry rotation speed 0.6s, collimation 1.25mm, helical pitch 1.375, and
scan field of view (SFOV) 50cm. Images were reconstructed in the projection space with 5mm/
5mm slice thickness and interval for axial images.
Data analysis
All CT images were reviewed by two experienced radiologists who were blind to presenting
symptoms and endoscopic results. Disagreement was infrequent and resolved by joint re-evalu-
ation. Material decomposition images using the water- and iodine- basis material pair were
reconstructed from the single spectral CT acquisition. Iodine density (ID) in the lesions was
derived from the iodine-based MDCT images and normalized to the ID in the psoas muscle
(normalized iodine density (NID) = ID (in lesion) / ID (in psoas)). The ROI sizes ranged from
35 mm2 to 55mm2 based on the lesion size and shape. ROIs were placed on solid regions avoid-
ing areas with obvious features of cystic or necrotic change. Measurements were performed
three times at three consecutive image levels, and mean values were calculated. Consistency in
size, shape, and position of ROI between the two phases was maintained by loading the images
of the double phases simultaneously into the workstation, and by using the copy and paste
functions between phases. The difference of ID and NID between AP and VP in low grade can-
cer groups and high grade cancer groups was calculated (Figs 1 and 2).
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Statistical analysis
Iodine densities were presented as mean values ± standard deviation (SD). A two-sample t test
was performed to compare the ID and NID in AP and VP of the various groups. Threshold val-
ues were created and determined by receiver operating characteristic (ROC) curves, and led to
the optimal values of probabilities to differentiate patient in the low grade group from the high
grade group. Diagnostic capability was determined by calculating the area under receiver oper-
ating characteristic curve. The best sensitivity and specificity, defined as the maximal sensitivity
Fig 1. A 65-year-old man with pathologically confirmed low grade cancer(white arrow). iodine-based material decomposition images from single
spectral CT acquisition (a) Coronal arterial phase, (b) Sagittal arterial phase.(c) Coronal venous phase (d) Sagittal venous phase.
doi:10.1371/journal.pone.0147756.g001
Fig 2. A 53-year-old female with pathologically confirmed high grade cancer (white arrow). iodine-based material decomposition images from single
spectral CT acquisition (a) Coronal arterial phase, (b) Sagittal arterial phase.(c) Coronal venous phase (d) Sagittal venous phase.
doi:10.1371/journal.pone.0147756.g002
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and maximal specificity values, was achieved by using the optimal thresholds. All data were
analyzed using dedicated statistical software (SPSS for Windows, version 19.0). A P value of
less than 0.05 was considered statistically significant.
Results
Colon distention
Colon distention was assessed by measuring the greatest cross-sectional diameter (from outer
wall to outer wall) of each colon segment including the rectum, sigmoid colon, descending
colon, transverse colon, ascending colon, and cecum. Optimal imaging signified that the seg-
ment was well distended, with uniform visualization of the intestinal wall, and a recognizable
fold pattern. In our study, 97.53% (79/81) of patients were optimally distended on CT-WE.
Quantative analysis
Evaluation of low grade cancer and high grade cancer in ID and NID is shown in Figs 3 and 4.
The ID and NID values of the low grade cancer were, respectively, 14.65±3.38mg/mL and 1.70
±0.33 in AP, and 21.90±3.11mg/mL, 2.05± 0.32 in VP. The ID and NID values of the high
grade cancer group were 20.63±3.72mg/mL and 2.95±0.72 in AP, and 26.27±3.10mg/mL and
3.51±1.12 in VP, respectively. There was a significant difference for ID and NID between the
low grade and high grade cancer groups in both AP and VP (all p<0.001).
Using the ROC analysis, we obtained the thresholds for ID and NID to optimize both the
sensitivity and specificity for differentiating low grade cancer from high grade cancer. We com-
pared ROC curves of ID and NID both in AP and VP (Fig 5, Table 1). Among them, the NID
in AP provided the highest value of the area under the curve (AUC) for ROC study (p<0.001).
Using the threshold value of 1.92 for NID in AP, one could obtain the sensitivity of 70.3% and
the specificity of 97.7% with AUC = 0.95.
Fig 3. Iodine densities for the low grade cancer and high grade cancer groups.
doi:10.1371/journal.pone.0147756.g003
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Fig 4. Iodine densities for the low grade cancer and high grade cancer groups.
doi:10.1371/journal.pone.0147756.g004
Fig 5. Receiver operating characteristic (ROC) curve of colon cancer grading. ROC analysis indicated that normalized ID (NID) of 1.92 in arterial phase
(AP) provided 70.3% in sensitivity and 97.7% in specificity in differentiating low graded cancer from high grade cancer with the area-under-curve (AUC) of
0.953.
doi:10.1371/journal.pone.0147756.g005
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Discussion
Colon cancer is the most common digestive cancer in many countries [13–17]. Diagnosis is
usually based on invasive colonoscopy, which provides direct visualization of lesions and
allows for biopsies. Recent improvements in CT have allowed for minimally invasive large
bowel evaluation at a substantial reduction in cost and patient risk. A critical technical require-
ment for CT evaluation of large bowel is full distension of a cleansed lumen with complete sep-
aration of the intestinal walls. In our study all patients received CT-WE for bowel distension,
with 97.53% optimally imaged. Two patients failed to undergo optimal imaging due to an
unsuccessful enema. Because these two patients’ colon lesions were obvious, diagnosis was not
affected. Luminal collapse or incomplete colonic filling may lead to false-negative outcomes as
polyps and small colorectal tumors can be obscured [18]. However, CT-WE offered excellect
visualization of the colonic wall due to parietal enhancement by iodine contrast, as well as good
contrast between wall, water-filled lumen, and pericolic fat [19].
Unlike conventional CT imaging which produces only polychromatic CT-number images,
dual energy spectral CT acquisition is a novel imaging technique which generates monochro-
matic and material decomposition images. This is accomplished by quickly alternating high
and low tube voltages on adjacent views during gantry rotation. The monochromatic images
provide better contrast resolution than conventional polychromatic images, whereas material
decomposition images offer material density measurement. Quantitative iodine density mea-
surement may be used to differentiate low and high grade colorectal carcinoma. Although
scanning parameters were consistent in all patients, individual differences were present. In
order to minimize these differences, NID was calculated except absolute iodine density.
According to our results, low grade cancer’s ID in AP and VP were 14.65±3.38mg/mL and
21.90±3.11mg/mL, respectively. Low grade cancer’s NID in AP and VP were 1.70±0.33 and
2.05± 0.32, respectively. High grade cancer’s ID in AP and VP were 20.63±3.72 mg/mL and
26.27±3.10 mg/mL, respectively. High grade cancer’s NID in AP and VP were 2.95±0.72 and
3.51± 1.12, respectively. There was significant difference for ID or NID between low grade and
high grade cancer in AP or in VP (p<0.001). High grade cancer has higher iodine density than
low grade cancer. Other parts of the tumor had the similar reports about blood supply and
tumor grading [20, 21]. Using the ROC analysis, we obtained the thresholds for ID and NID to
optimize both the sensitivity and specificity for differentiating low grade from high grade can-
cer. Receiver operating characteristic analysis revealed that the area under the ROC curve for
NID in AP was greatest. The diagnostic value of NID in AP was best for differentiating low
grade and high grade cancer. When diagnostic threshold of NID in AP was 1.92, the sensitivity
was 70.3% and the specificity was 97.7%. The diagnostic value of NID in AP was superior to
the other three values for differentiating low grade from high grade cancer.
The majority of previous radiological studies evaluating tumor grading involves MRI imag-
ing [22–24]. Pathological angiogenesis, triggered by activation of certain cellular signal path-
ways, is considered a key factor for solid tumors to develop, grow, and metastasize [25].
Colorectal carcinoma has been found highly associated with angiogenesis, and malignant rectal
Table 1. The area under the curve (AUC) for ROC study.
Item AUC P 95% confidence interval
ID in AP 0.886 0.000 0.814–0.957
ID in VP 0.853 0.000 0.767–0.939
NID in AP 0.953 0.000 0.914–0.991
NID in VP 0.895 0.000 0.828–0.961
doi:10.1371/journal.pone.0147756.t001
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tumor tissue generally has greater angiogenic activity than normal rectal tissue [26–29]. GSI is
a noninvasive imaging technique demonstrating the iodine density variance between low grade
and high grade cancer groups. Iodine density was associated with contrast concentration in
vessels which may reflect blood vessel density, tumor activity, and invasion. As such, GSI is a
potential tool for exposing angiogenesis and metabolic activity in rectal adenocarcinoma.
Material decomposition images in spectral CT imaging generate quantitative material density,
such as iodine density. These measurements may provide an alternative method to directly
evaluate tumor treatment and chemotherapy response.
Several limitations exist in this study. First, this investigation reflects our preliminary results
in a small sample of patients. In the low grade group, only poorly differentiated colon adeno-
carcinoma and signet ring cell carcinoma were included. Other tumors such as medullary car-
cinoma, carcinosarcoma, etc, were not considered. This may influence results. Second, further
clinical trials need to be performed to confirm our quantitative data since iodine density may
be influenced by injection parameters and cardiopulmonary status. This was in part offset by
using the normalized iodine density which minimized individual differences and thereby
reduced error. Third, the ROIs were placed as far intralesionally as possible to improve accu-
racy, however slice selection may influence outcomes. Although the average iodine density
value was calculated, measurement deviation cannot be absolutely avoided. Last, this study was
focused on the use of quantitative measurement generated by using CT spectral imaging. The
quantitative assessment of iodine- and water-based images could be assessed in future studies
to determine their clinical value.
Conclusions
Spectral CT imaging generated material decomposition images for quantitative depiction of
colorectal carcinoma. The quantitative measurement of iodine density and normalized iodine
density in AP and VP can provide useful information to differentiate low grade tumors from
high grade tumors. NID in AP was superior to the other three values, and provided more infor-
mation for clinical diagnosis and consequently treatment.
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